RPG LifeScience. (RPGLIFE)
STALWARTFairStock Score: 18/100 — RISKY
Score breakdown: P/E: 1/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹2,011.4 |
| Market Cap | ₹3,100.07 Cr |
| P/E Ratio | 29.51 |
| ROCE | 32.8% |
| ROE | 53.41% |
| Dividend Yield | 1.07% |
| Profit Growth | -18.32% |
| Debt/Equity | — |
| Sales Growth | 4.24% |
| Promoter Holding | 72.95% |
| 52-Week Range | ₹1,733 — ₹2,725 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹230.74 |
RPG LifeScience. trades with a P/E ratio of 29.51, ROCE of 32.8%, ROE of 53.41%, profit growth of -18.32%. The FairStock Score of 18/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer